BDBM160834 US9682976, 5

SMILES CC1(C)CC(CC2CCCN12)Nc1nc(Nc2cc(F)c3OC(C)(C)c4nnnn4-c3c2)ncc1F

InChI Key InChIKey=JVXBWQBFQUVQMC-UHFFFAOYSA-N

Data  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 160834   

TargetInterleukin-2(Human)
Rigel Pharmaceuticals

US Patent
LigandPNGBDBM160834(US9682976, 5)
Affinity DataEC50: <500nMAssay Description:Primary T cell stimulation and IL2 ELISA: Human primary T cells (100,000 cells per well) were pre-incubated with or without test compound in Yssel...More data for this Ligand-Target Pair
In DepthDetails
US Patent